In the study of 165 patients with AHF, this definition has proven hepcidin and sTfR as useful biomarkers for identifying ID (depicting both depleted iron stores and unmet need for iron utilization) regardless of anemia, as well as a predictor of poor outcomes in patients with the most severe ID [68]. The gene discussed is HAMP; the disease is anemia.